Study finds Pfizer vaccines protect kids from omicron infection

Plus: Amazon’s pandemic boom is causing trademark backlogs

A real-world study of Pfizer’s Covid vaccine in kids published today found that it reduced risk of infection in kids 31% for ages 5-11 and by 59% among children 12-15. And those kids who were infected had milder illnesses and needed less rest and recovery time. This study supplements previous studies that found the vaccine helped reduce risk of infection from the delta variant. The study, which looked at over 1300 kids in four different states, helped underscore the protective nature of the vaccines against Covid-19.

Do you have comments or questions? Email us at health@forbes.com

More Covid News

Covid-19 may have claimed far more lives than official records indicate, according to a new study published in the Lancet, which found that excess deaths during the pandemic years has so far exceeded 18 million people worldwide.

Delays in non-essential medical procedures in the United Kingdom may stretch to two years due to the pandemic. 

The Department of Justice said it has brought civil and criminal enforcement actions involving $8 billion worth of alleged fraud stemming from Congress’ $2 trillion Covid relief bill passed in March 2020, and that it has appointed a director of Covid-19 fraud enforcement.

What Else We Are Reading

• How hybrid working took hold in science (Nature)

• ‘Haven’t we learned anything?’: Experts warn of disastrous consequences if pandemic funding dries up (Stat)

• A deep dive on the evolution of COVID and its variants (Popular Science)